Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide in haploidentical SCT for high-risk hematologic malignancies
NCT01374841Phase 2Unknown
- Sponsor
- European Institute of Oncology
- Start
- Aug 2010
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in hematologic neoplasm, sponsored by European Institute of Oncology. Status: unknown.
02
Drugs
cyclophosphamide
03
Conditions
hematologic neoplasm
Beyond the preview
Go deeper on NCT01374841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01374841.